We act as part of your executive team, saving you time, energy and resources by having an immediate presence in the Silicon Valley and Boston for your growing startup.
Talia Cohen, MBA
Strategy & Business Development
Founder, Managing Partner
Over 20 years of experience in Management, Business Development and Finance. Passionate and results driven.
Lead CICC (CA-Israel-Chamber of Commerce) for over 6 years, worked with hundreds of Israeli startups to introduce them to the US market, and with corporates and VCs in different industries including MedTech.
Prescreened, mentored and connected startups to potential customers, partners and investors. Recruited hundreds of new members and advisors to the CICC, including VCs, corporates, start-ups, service providers, universities, and government officials.
Founded the annual conferences: CiMED ; CiConnect; The Israeli Cyber Innovation
Served as VP of Lending and Business Development at Bank Leumi USA.
Charles Barr, MD, MPH
Chief Scientist
Partner
Passionate about improving health care and outcomes of patients with serious disease through better data, evidence and decisions.
Extensive leadership experience in scientific research, the pharma industry, clinical medicine, health care quality improvement and managed care.
Leverages innovations in data science, informatics, analytic and technology platforms to help clients understand causal mechanisms of disease, optimize drug development, and use of diagnostic tests and treatments. Enable use of real-time data, evidence and knowledge to inform decisions about populations and individual patients.
Works with healthcare delivery, patient advocacy and research organizations; pharma, diagnostic and medical device companies, government regulators and policy groups; investors and technology companies.
Asaf Bar, BA
Medical Devices
Partner
20 years of senior level business development, upstream marketing, and finance roles in digital health, medical devices and biopharma companies. He has hands-on expertise in growing successful businesses by creating strategies, leading business development (mergers, acquisitions, licensing, joint ventures), commercialization, fundraising and financial analyses.
Asaf holds a Bachelor of Arts degree in Economics and Business Administration from the University of Haifa.
Worked for J&J, Omrix Biopharmaceuticals, Lumenis, PolyPid and Sensifree.
Tanya Yankelevich, BSc
Start-up Operations & Growth
Partner
Over 25 years of experience in building, scaling and managing Software Product & Operations organizations.
Served as VP Customer Delivery for Amdocs and in VP and C-level roles for several software companies of various sizes, leading integrated Product and Customer Engagement organizations.
Gained vast experience in delivering products and solutions to enterprise customers all over the world, including deal negotiations, planning and budget management, development and delivery; efficiently managing multinational teams.
In addition, holds certifications in Data Privacy as DPO, Privacy Manager and Technologist.
Jonathan Steinberger, MD
Market Validation, Clinical Insight
Partner
A vascular and interventional radiologist at Cedars Sinai Medical Center, and an adjunct assistant professor of the Dotter Interventional Institute at Oregon Health & Science University. Dr. Steinberger received his A.B. from Harvard University and his M.D. from Mount Sinai School of Medicine. Jonathan was a healthcare strategy consultant for Easton Associates, subsequently Navigant Health, where he advised and interfaced with a great number of medical device, pharma, and biotech companies. Dr. Steinberger has cofounded 2 life science startups.
Deepa Madhavan, MBA
Health Care Consumer
Partner
Deepa is an investor, mentor and advisor to startups, accelerators that meet the needs of healthcare consumers in bold and new ways.
Senior Director, Digital Innovation Lab Leader at Baxter.
Former innovation leader at Anthem,
Blue Shield, Deloitte, GE Healthcare
Noam Frey, MD, MBA
Biopharma
Partner
18 years of experience in the pharmaceutical industry; successfully managing teams, products, and key opinion leaders’ relations.
Dr. Frey worked on different therapeutic solutions and in a variety of companies of all sizes, where he was involved directly in 6 pharma products launches.
Most recently Dr. Frey served as VP, Medical Affairs and Pharmacovigilance at Jazz Pharmaceuticals in Palo Alto, California, where he oversaw a large portion of the R&D organization. Prior to his tenure at Jazz Dr. Frey was VP, Medical Affairs at Intermune until its acquisition by Roche-Genentech in 2014.
Today, Dr. Frey is consulting and advising to multiple biotech, pharma, and technology companies.
Jeff Voigt, MBA, MPH, BA
Reimbursement
Partner
Jeff is an expert in the fields of reimbursement, evidence development and assessment, and cost effectiveness/value analysis and heads up his own firm – Medical Device Consultants of Ridgewood, LLC. In this capacity, Jeff has earned tens of millions of dollars for his clients in additional reimbursements. He has authored over 35 peer reviewed journal articles in these areas. He is also an Associate Editor of a peer reviewed journal, Cost Effectiveness and Resource Allocation and; serves as a peer reviewer for a number of medical economic and evidence assessment journals. Jeff has also helped set up registries for companies to gather clinical data for outcome assessment and ultimate publication.
Uli K. Chettipally, MD, MPH
Physician, Clinical Intelligence Innovation
Partner
Physician, researcher, author, innovator. Was
the CTO of CREST Network, he designed, developed and implemented a region-wide clinical decision support platform to deliver
real-time predictive analytics at the point of care.
Received the Pioneer Award for Innovation
from Kaiser Permanente and Morris F. Collen Research Award from The Permanente Medical Group. President-elect, San Mateo County Medical Association; Chairman, Society of Physician Entrepreneurs, San Francisco Bay Area chapter. Author of “Punish The Machine” book.
Limor Amit, MD
Oncologist, Entrepreneur
Partner
Medical oncologist with over 12
years of clinical experience in the Davidoff oncology center.
Founded DocBoxMD to create an AI based, advanced, complex clinical decision support system in order to optimize and personalize patient care.
Advises biotech companies on strategy and business development based on
her clinical experience.
David Libby, BA
Public relations
Partner
Results-driven and success-oriented public relations professional with over 25 years of developing and executing award-winning communications campaigns for clients. In the biotech and healthcare sector, he has represented Novartis Diagnostics, BayBio, The Bay Area Area Air Quality Management District, among others.
Omer Malchin, MBA
Marketing and Branding
Partner
Applying strategic and creative thinking to a wide variety of brand, product and marketing initiatives.
Founder and CEO of Moxie Method.
Yan Chow, MD, MBA
Digital Health
Advisor
Global Healthcare Industry Leader at Automation Anywhere. Previous roles include:
Medical Director for Digital Medicine in the Translational Medicine group at Amgen
Chief Innovation Officer at LongView International Technology Solutions
The national Director of the Innovation & Advanced Technology group (IAT) at Kaiser Permanente
Yaron Hadad, PhD
Digital Health
Advisor
Mathematical physicist whose expertise is in general relativity and nonlinear mathematics.
Co-founder and the Chief Scientist of Nutrino Health (acquired by Medtronic), where he leads the technological and scientific efforts of the company.
Currently leads the AI and Data Science for Medtronic Diabetes, specifically the efforts to use Machine Learning to build a Personalized Close Loop system (an artificial pancreas).
Kwame Ulmer, MS, MBA
Medical Device Regulatory Strategy
Advisor
Twenty years of experience evaluating medical technologies in the government and serving in senior operating roles at medical device companies. This experience allows him to help companies at all stages efficiently navigate global regulatory agencies.
Kwame has particular expertise in all aspects of the USFDA, from premarket applications to post market compliance. Kwame has in depth knowledge of the cross-functional activities needed to take a medical device from concept to product launch in markets including North America, EU, EMEA, China and LATAM.